Ledger.Open graph →
SEC Form D · filed June 25, 2015

CytomX Therapeutics, Inc

Offering
$70.0M
Sold
$70.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Tim W. Shannon · South San Francisco, CADirectorFrederick W. Gluck · South San Francisco, CADirectorSean Mccarthy · South San Francisco, CAExec · DirectorElaine V. Jones · South San Francisco, CADirectorHoyoung W. Huh · South San Francisco, CADirectorNeil W. Exter · South San Francisco, CADirectorKevin G. Quinn · Rockville, MDDirectorLuis T. Gutierrez, Jr · Rockville, MDDirectorLithotripters Inc · Austin, TXDirectorRachel V. Humphrey · South San Francisco, CADirectorJennifer Thomson · GRAND CAYMAN, Cayman IslandsExec · DirectorJohn Walley · GRAND CAYMAN, Cayman IslandsDirectorRonan Daly · GRAND CAYMAN, Cayman IslandsDirectorDavid Readerman · SAN FRANCISCO, CAExec · DirectorDavid Z. Steinberg · Danville, CADirectorDawn R. Odams · Wallingford, CTDirectorRachel V. Humphrey · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗